Arcellx

Biotechnology
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

$6.7B

Market Cap • 27/04/2026

2014

(há 12 anos)

Fundação

2022

(há 4 anos)

IPO

NASDAQ

Listagem

Flag of Estados Unidos

Estados Unidos

País